To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at For Technical questions please contact Thank you.

NCI Selects ATCC to Provide End-to-End Cancer Epidemiology Services

Five-year contract includes customized support for collection, tracking, storage and distribution of human biospecimens and environmental samples.

MANASSAS, Va., (March 14, 2017) — The National Cancer Institute (NCI) recently awarded ATCC, a global leader in biological materials development, management and standards, a five-year indefinite-delivery/indefinite-quantity (IDIQ) contract to support the Division of Cancer Epidemiology and Genetics’ (DCEG) Molecular Epidemiology Assay Support (MEAS) program.

DCEG’s mission is to conduct population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The MEAS program provides support services for studies on the genetic and other cellular events that influence the onset of different types of cancer.

Under the contract, ATCC will provide collection supplies to study sites; perform aliquoting and advanced molecular assays; and provide short-term storage for human biospecimens and environmental samples obtained through family and population-based collection efforts, both domestically and internationally. ATCC will track all specimens using a customized biospecimen inventory and resource management system, ensuring that specimens are safeguarded appropriately for use in long-term epidemiology research projects.

“We understand that the proper collection, tracking and storage of specimens is of critical importance to cancer research, and take pride in maintaining and distributing these unique samples to the global research community,” said Dr. Joseph Leonelli, vice president for ATCC’s Microbiology and Government Solutions business. “We are excited to expand our relationship with The National Cancer Institute through this program, and look forward to expanding our clinical study capabilities to support advancements in cancer research.”

About ATCC

ATCC is a leader in biological materials management supporting the scientific community and government with research and development, products, and services in support of global health issues. With a history of innovation spanning more than 90 years, ATCC offers the world’s largest and most diverse collection of human and animal cell lines, microorganisms, biological products, and standards. ATCC is a non-profit organization with headquarters in Manassas, Va.